Centre Georges François Leclerc; Service Pharmacie, Bp 77980

Dijon 21000

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Non-Small-Cell Lung Carcinoma

Studies at this site

• A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy — Stopped early
• A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment — Completed